Skip to content
Announcement:

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

Listen to our CEO, Dr Mike Nicholds talking about our company

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

Get our latest updates straight to your inbox